|
Ferumoxytol Clinical Trials
4 actively recruiting trials across 4 locations
Also known as: Feraheme, Ferumoxytol Non-Stoichiometric Magnetite, feraheme
Pipeline
Phase 1: 1Phase 2: 1Phase 3: 1Phase 1/2: 1
Top Sponsors
- OHSU Knight Cancer Institute1
- Jonsson Comprehensive Cancer Center1
- Heike E Daldrup-Link1
- Children's Hospital of Philadelphia1
Indications
- Cancer3
- Pulmonary Vein Stenosis1
- Heart Disease1
- Cranial Nerve Disorder1
- Central Nervous System Neoplasm1
Los Angeles, California1 trial
Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
UCLA / Jonsson Comprehensive Cancer Center
Phase 3
Stanford, California1 trial
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
Stanford University Cancer Institute
Phase 1/2
Portland, Oregon1 trial
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
OHSU Knight Cancer Institute
Phase 2
Philadelphia, Pennsylvania1 trial
Calculating Wall Shear Stress in Infant Pulmonary Veins
Children's Hospital of Philadelphia
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.